Los puntos clave no están disponibles para este artículo en este momento.
This JAMA Insights Clinical Update discusses management options for women with vulvovaginal atrophy, focusing on the systemic safety of estrogen-based therapies and shared decision-making based on preference, cost, and adverse effect profile.
Carolyn Crandall (Fri,) studied this question.